Antiviral Agents Used to Treat Hepatitis B Virus Infection
Last updated: January 20, 2010
A 38-year-old Vietnamese woman with HBeAg-positive chronic hepatitis B presents for evaluation. She has had serum alanine aminotransferase (ALT) levels of 80-120 U/L and HBV DNA level of 2 million copies/mL (approximately 400,000 IU/ml) over the past year and no evidence of spontaneous loss of HBeAg. She is asymptomatic and had a normal abdominal ultrasound within the prior 6 months. She has never received therapy for hepatitis B.
Which of the following statements is TRUE regarding the use of available therapeutic agents for patients with chronic hepatitis B infection?